![Alessandro Riva](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alessandro Riva
Directeur Général chez
TRANSGENE
Fortune : 4 M $ au 31/05/2026
Profil
Alessandro Riva was the founder of Intima Bioscience, Inc., founded in 2021, where the title held was Chief Executive Officer from 2021 to 2023.
Dr. Riva is also the founder of Breast Cancer International Research Group Ltd.,Cancer International Research Group..
Dr. Riva is Chairman & Chief Executive Officer at Transgene SA since 2023, Independent Director at Century Therapeutics, Inc. since 2021, Independent Non-Executive Director at BeOne Medicines Ltd. since 2022, and Independent Director at Bicycle Therapeutics Plc starting in 2025.
Former positions include Chief Executive Officer-Innovation Business at Glenmark Pharmaceuticals Ltd., Director at Ichnos Glenmark Innovation, Inc. in 2021, Director at Century Therapeutics, Inc. in 2021, Executive VP-Oncology Therapeutics at Gilead Sciences, Inc. from 2017 to 2019, President at Novartis Oncology, Inc. from 2005 to 2016, VP, Head-Oncology Development & Medical Affairs at Novartis AG from 2005 to 2016, and EVP, Head-Oncology Development & Medical Affairs at Novartis Pharmaceuticals Corp.
Education includes undergraduate and doctorate degrees from the University of Milan.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BEONE MEDICINES LTD. 0,01 % | 22/05/2026 | 192 530 ( 0,01 % ) | 4 M $ | 31/05/2026 |
TRANSGENE SA 0,03 % | 31/12/2024 | 93 075 ( 0,03 % ) | 90 692 $ | 31/05/2026 |
| 11/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Alessandro Riva
| Sociétés | Poste | Début |
|---|---|---|
| BEIGENE LTD | Directeur/Membre du Conseil | 01/02/2022 |
| CENTURY THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/05/2021 |
| TRANSGENE | Directeur Général | 01/06/2023 |
| BICYCLE THERAPEUTICS PLC | Directeur/Membre du Conseil | 25/03/2025 |
Anciens postes connus de Alessandro Riva
| Sociétés | Poste | Fin |
|---|---|---|
Intima Bioscience, Inc.
 Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products to treat cancer | Directeur Général | 01/04/2023 |
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Directeur Général | 21/05/2021 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 06/03/2019 |
| NOVARTIS AG | Corporate Officer/Principal | 01/12/2016 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | President | 01/01/2016 |
Formation de Alessandro Riva
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Glenmark Pharmaceuticals Ltd.
 Glenmark Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of Milan
 University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bicycle Therapeutics Plc
 Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Breast Cancer International Research Group Ltd.
 Breast Cancer International Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Breast Cancer International Research Group Ltd. is an organization focused on breast cancer research. The private company is based in Edmonton, Canada. The Canadian company was founded by Alessandro Riva. | Commercial Services |
Intima Bioscience, Inc.
Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products to treat cancer | Health Technology |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Century Therapeutics, Inc. /Old/
 Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Cancer International Research Group |
